X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2065) 2065
Publication (163) 163
Book Review (35) 35
Book Chapter (11) 11
Book / eBook (9) 9
Magazine Article (2) 2
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1966) 1966
index medicus (1199) 1199
female (1093) 1093
male (955) 955
venous thromboembolism (796) 796
middle aged (740) 740
risk factors (698) 698
adult (638) 638
aged (551) 551
peripheral vascular disease (522) 522
thrombosis (503) 503
hematology (473) 473
thromboembolism (471) 471
venous thrombosis - physiopathology (464) 464
venous thrombosis (385) 385
deep-vein thrombosis (348) 348
anticoagulants - therapeutic use (336) 336
treatment outcome (310) 310
pulmonary embolism (251) 251
surgery (251) 251
venous thromboembolism - physiopathology (245) 245
risk (237) 237
pulmonary embolism - physiopathology (236) 236
risk-factors (224) 224
venous thrombosis - etiology (224) 224
retrospective studies (222) 222
aged, 80 and over (209) 209
pulmonary-embolism (208) 208
diagnosis (194) 194
risk assessment (193) 193
molecular-weight heparin (191) 191
pregnancy (188) 188
animals (184) 184
adolescent (177) 177
medicine, general & internal (176) 176
anticoagulants (175) 175
prevention (168) 168
care and treatment (167) 167
prospective studies (164) 164
disease (162) 162
venous thrombosis - diagnosis (155) 155
follow-up studies (150) 150
prognosis (149) 149
time factors (149) 149
medicine & public health (143) 143
deep venous thrombosis (142) 142
cardiac & cardiovascular systems (141) 141
young adult (138) 138
thrombosis - physiopathology (136) 136
venous thrombosis - drug therapy (135) 135
recurrence (134) 134
venous thromboembolism - etiology (130) 130
incidence (127) 127
management (126) 126
venous thrombosis - epidemiology (124) 124
pulmonary embolism - diagnosis (122) 122
venous thrombosis - prevention & control (122) 122
anticoagulants - adverse effects (121) 121
anticoagulants - administration & dosage (119) 119
venous thromboembolism - epidemiology (119) 119
coagulation (118) 118
research (117) 117
prevalence (116) 116
thrombophilia (115) 115
venous thromboembolism - prevention & control (115) 115
cancer (114) 114
mortality (114) 114
venous thrombosis - complications (113) 113
abridged index medicus (112) 112
health aspects (112) 112
pulmonary embolism - etiology (111) 111
factor-v-leiden (109) 109
thromboembolism - physiopathology (108) 108
therapy (105) 105
venous thrombosis - therapy (105) 105
respiratory system (104) 104
deep vein thrombosis (103) 103
activated protein-c (102) 102
analysis (102) 102
acute disease (101) 101
venous thrombosis - diagnostic imaging (96) 96
blood clot (95) 95
thrombophilia - physiopathology (95) 95
heparin (94) 94
severity of illness index (91) 91
complications (90) 90
cohort studies (89) 89
venous thromboembolism - drug therapy (89) 89
blood coagulation (88) 88
case-control studies (88) 88
child (88) 88
clinical neurology (86) 86
mutation (86) 86
stroke (83) 83
d-dimer (82) 82
heparin, low-molecular-weight - therapeutic use (82) 82
predictive value of tests (82) 82
internal medicine (81) 81
prophylaxis (80) 80
heparin - therapeutic use (79) 79
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2002) 2002
French (25) 25
Russian (22) 22
Spanish (11) 11
German (10) 10
Japanese (8) 8
Chinese (3) 3
Hungarian (3) 3
Czech (2) 2
Italian (1) 1
Korean (1) 1
Polish (1) 1
Romanian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 11/2015, Volume 113, Issue 6, pp. 1176 - 1183
Summary Venous thromboembolism (VTE) is a multifactorial disease. Major provoking factors (e. g. surgery, cancer, major trauma, and immobilisation) are... 
Theme Issue Article | Inflammation | Atherothrombosis | Venous thromboembolism | Etiopathogenesis | CASE-FATALITY RATES | METABOLIC SYNDROME | etiopathogenesis | RISK-FACTORS | atherothrombosis | DEEP-VEIN THROMBOSIS | JAK2 V617F MUTATION | TUMOR-NECROSIS-FACTOR | CUSHINGS-SYNDROME | inflammation | PULMONARY-EMBOLISM | ARTERIAL CARDIOVASCULAR EVENTS | PERIPHERAL VASCULAR DISEASE | HOSPITALIZED MEDICAL PATIENTS | HEMATOLOGY | Venous Thrombosis - diagnosis | Prognosis | Humans | Venous Thrombosis - blood | Pulmonary Embolism - epidemiology | Atherosclerosis - epidemiology | Inflammation - blood | Venous Thromboembolism - blood | Venous Thrombosis - immunology | Communicable Diseases - physiopathology | Pulmonary Embolism - immunology | Blood Coagulation | Atherosclerosis - diagnosis | Inflammation - diagnosis | Venous Thromboembolism - epidemiology | Venous Thromboembolism - diagnosis | Inflammation Mediators - immunology | Venous Thromboembolism - immunology | Atherosclerosis - immunology | Risk Assessment | Signal Transduction | Atherosclerosis - physiopathology | Communicable Diseases - epidemiology | Risk Factors | Venous Thrombosis - physiopathology | Inflammation - immunology | Inflammation - epidemiology | Pulmonary Embolism - blood | Atherosclerosis - blood | Pulmonary Embolism - diagnosis | Animals | Venous Thromboembolism - physiopathology | Venous Thrombosis - epidemiology | Communicable Diseases - immunology | Inflammation - physiopathology | Pulmonary Embolism - physiopathology
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 06/2010, Volume 103, Issue 6, pp. 1116 - 1127
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 1/2010, Volume 102, Issue 1, pp. 14 - 25
Due to the aging of the populations of developed countries and a common occurrence of risk factors, it is increasingly probable that a patient may have both... 
DOXORUBICIN-INDUCED CARDIOTOXICITY | TRASTUZUMAB-RELATED CARDIOTOXICITY | ONCOLOGY | SPORADIC COLORECTAL ADENOMAS | VASCULAR-DISRUPTING AGENTS | TYROSINE KINASE INHIBITOR | N-ACETYLCYSTEINE | DAUNORUBICIN-INDUCED CYTOTOXICITY | HIGH-DOSE CHEMOTHERAPY | EARLY BREAST-CANCER | ATRIAL-FIBRILLATION | Atrial Fibrillation - chemically induced | Cardiovascular Diseases - prevention & control | Humans | Patient Care Team | Atrial Fibrillation - physiopathology | Ventricular Dysfunction, Left - chemically induced | Flavonoids - therapeutic use | Cardiotonic Agents - therapeutic use | Venous Thromboembolism - prevention & control | Cardiovascular System - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Antineoplastic Agents - adverse effects | Hypertension - chemically induced | Hypertension - prevention & control | Polyphenols | Free Radical Scavengers - therapeutic use | Acetylcysteine - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Diseases - diagnosis | Heart - physiopathology | Cardiovascular Diseases - physiopathology | Stroke Volume - drug effects | Anticoagulants - therapeutic use | Cardiovascular System - drug effects | Hypertension - physiopathology | Ventricular Dysfunction, Left - physiopathology | Ventricular Dysfunction, Left - prevention & control | Cardiovascular Diseases - microbiology | Animals | Blood Coagulation - drug effects | Venous Thromboembolism - physiopathology | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Phenols - therapeutic use | Venous Thromboembolism - chemically induced | Heart - drug effects | Cardiovascular Diseases - chemically induced | Atrial Fibrillation - prevention & control | Antimitotic agents | Complications and side effects | Aging | Physiological aspects | Dosage and administration | Research | Cardiovascular diseases | Antineoplastic agents | Risk factors | Index Medicus | Review
Journal Article
Journal Article
Head & Neck, ISSN 1043-3074, 06/2017, Volume 39, Issue 6, pp. 1249 - 1258
Journal Article
Journal Article